Deutsche Bank
CGEM icon

Deutsche Bank’s Cullinan Oncology CGEM Stock Holding History

Deutsche Bank’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.23M Sell
367,906
-218,730
-37% -$2.81M ﹤0.01% 1276
2025
Q4 		$6.07M Buy
586,636
+14,898
+3% +$134K ﹤0.01% 1229
2025
Q3 		$3.39M Buy
571,738
+4,957
+0.9% +$36.3K ﹤0.01% 1481
2025
Q2 		$4.27M Sell
566,781
-8,750
-2% -$70.3K ﹤0.01% 1309
2025
Q1 		$4.36M Sell
575,531
-4,605
-0.8% -$44.2K ﹤0.01% 1314
2024
Q4 		$7.07M Buy
580,136
+19,263
+3% +$277K ﹤0.01% 1165
2024
Q3 		$9.39M Buy
560,873
+5,806
+1% +$103K ﹤0.01% 1031
2024
Q2 		$9.68M Buy
555,067
+5,791
+1% +$123K ﹤0.01% 1018
2024
Q1 		$9.36M Buy
549,276
+3,692
+0.7% +$57K ﹤0.01% 1047
2023
Q4 		$5.56M Buy
545,584
+540,967
+11,717% +$4.79M ﹤0.01% 1208
2023
Q3 		$41.8K Sell
4,617
-3,676
-44% -$38.3K ﹤0.01% 3438
2023
Q2 		$89.2K Sell
8,293
-7,670
-48% -$81.5K ﹤0.01% 3321
2023
Q1 		$163K Buy
15,963
+3,654
+30% +$40.3K ﹤0.01% 3102
2022
Q4 		$130K Buy
12,309
+204
+2% +$2.48K ﹤0.01% 3203
2022
Q3 		$155K Sell
12,105
-1,993
-14% -$26.9K ﹤0.01% 3087
2022
Q2 		$181K Sell
14,098
-264
-2% -$2.99K ﹤0.01% 3232
2022
Q1 		$150K Sell
14,362
-1,662
-10% -$22.5K ﹤0.01% 3413
2021
Q4 		$247K Buy
16,024
+822
+5% +$16.4K ﹤0.01% 3273
2021
Q3 		$343K Buy
15,202
+6,882
+83% +$184K ﹤0.01% 3268
2021
Q2 		$214K Sell
8,320
-262
-3% -$8.06K ﹤0.01% 3747
2021
Q1 		$358K Buy
+8,582
New +$348K ﹤0.01% 3312

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return